Stryker Corporation
Capitalisation boursière
$127.2B
Rang mondial
#132
Sommet historique
$136.1B
2024-12-31
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 64% of the 367 companies we track (globally).
- Equivalent to 0.4% of United States's GDP (2025 data).
- Just above: #131 Vertex Pharmaceuticals Incorporated ($130.6B)
- Just below: #133 Newmont Corporation ($126.8B)
- Best year: 1998 (+48%). Worst year: 2008 (-46%).
Stryker Corporation Financial Breakdown (FY 2025)
Source: Yahoo Finance — SYK annual filings (2025) →$25.1B revenue · $5.1B operating income · $3.2B net income
- ●Operating margin: 20.1% on $25.1B in revenue.
- ●R&D is 6.5% of revenue ($1.6B).
- ●Net income margin: 12.9% — $3.2B in profit.
- ●Free cash flow: $4.3B (17.1% of revenue).
Cost / Operating Expenses
Total operating expenses $20.1B
Total
$19.3B
Capital Expenditures
$0.8B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$4.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
À propos de Stryker Corporation
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
Historique de la capitalisation boursière de Stryker Corporation (2026–2026)
Stryker Corporation vs Sector Peers by Market Cap
Comparer Stryker Corporation
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $127.2B | #132(↓13) | -5.1% |
| 2025 | $134.0B | #119(↓24) | -1.5% |
| 2024 | $136.1B | #95(↑4) | +21.4% |
| 2023 | $112.1B | #99(↑6) | +23.9% |
| 2022 | $90.5B | #105(↓3) | -7.5% |
| 2021 | $97.8B | #102(↓8) | +10.2% |
| 2020 | $88.7B | #94(↓2) | +18.2% |
| 2019 | $75.1B | #92(↑1) | +35.4% |
| 2018 | $55.5B | #93(↑12) | +2.4% |
| 2017 | $54.2B | #105(↑7) | +30.9% |
| 2016 | $41.4B | #112(↑18) | +30.8% |
| 2015 | $31.6B | #130(↓6) | -0.0% |
| 2014 | $31.6B | #124(↑10) | +27.5% |
| 2013 | $24.8B | #134(↑8) | +39.4% |
| 2012 | $17.8B | #142(↓12) | +12.0% |
| 2011 | $15.9B | #130(↑8) | -6.2% |
| 2010 | $16.9B | #138(↓13) | +7.9% |
| 2009 | $15.7B | #125(↓11) | +27.6% |
| 2008 | $12.3B | #114(↓18) | -46.3% |
| 2007 | $22.9B | #96(↑16) | +36.1% |
| 2006 | $16.8B | #112(↑8) | +24.3% |
| 2005 | $13.5B | #120(↓38) | -7.7% |
| 2004 | $14.7B | #82(↓5) | +13.7% |
| 2003 | $12.9B | #77(↑1) | +26.9% |
| 2002 | $10.2B | #78(↑30) | +15.2% |
| 2001 | $8.8B | #108(↑8) | +15.6% |
| 2000 | $7.6B | #116(↓9) | +45.6% |
| 1999 | $5.3B | #107(↑5) | +26.5% |
| 1998 | $4.2B | #112(↑7) | +48.3% |
| 1997 | $2.8B | #119(↓5) | +24.8% |
| 1996 | $2.2B | #114(↓8) | +13.9% |
| 1995 | $2.0B | #106(↓7) | +42.9% |
| 1994 | $1.4B | #99 |
Autres entreprises du secteur Santé
FAQ
What is Stryker Corporation's market cap?
Stryker Corporation (SYK) has a market capitalization of $127.2B, making it the #132 largest company in the world by market cap.
What was Stryker Corporation's highest market cap?
Stryker Corporation's all-time high market cap was $136.1B, reached in 2024-12-31. Its highest rank was #95 in 2024.
What sector is Stryker Corporation in?
Stryker Corporation is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.
How has Stryker Corporation's market cap changed over time?
Stryker Corporation has been tracked since 2026. Its market cap has grown by 0% from $127.2B in 2026 to $127.2B today.